Helēna Mikažāne

A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study

Won Park, Paweł Hrycaj, Volodymyr Kovalenko et al. · Annals of the Rheumatic Diseases · 2013 · 604 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study

Won Park, Dae‐Hyun Yoo, Pedro C. Miranda et al. · Annals of the Rheumatic Diseases · 2016 · 229 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis.

Svetlana Kozireva, Jekaterina Žestkova, Helēna Mikažāne et al. · PubMed · 2008 · 47 citations

Life Sciences, Immunology, Internal Medicine +14

Use of exploratory factor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19

Natalja Kakurina, A. Kadisa, Aivars Lejnieks et al. · Medicina · 2015 · 14 citations · Full text

Life Sciences, Immunology, Internal Medicine +15